
|Articles|November 1, 2012
Antiandrogen shows efficacy in elderly men with advanced prostate cancer
Bicalutamide monotherapy in men with locally advanced or metastatic prostate cancer is as initially effective as LHRH analogs but can be far more beneficial in preserving bone mineral density, muscle tone, sexual function, and quality of life, say British researchers.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves sildenafil oral film for men with erectile dysfunction
2
The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma, with Brian Shuch, MD
3
Pearls & Perspectives: Modern Semen Testing and Male Fertility Care, with Thomas Masterson, MD
4
Head-to-head analysis shows OS benefit with apalutamide vs darolutamide in mCSPC
5






